GlassScriptPhysician profile
Richard C Cherny
NPI 1659351484
$509.72
in general payments reported to CMS, 2019-2025
12 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $175 · 2021: $23.89 · 2023: $13.86 · 2024: $18.09 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $51.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $51.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $122.98 | 2019 | |
| Astellas Pharma US INC | $98.95 | 2020 | |
| Elekta, INC. | $91.36 | 2019 | |
| Pfizer INC. | $50.24 | 2019-2023 | |
| Welch Allyn | $33.70 | 2020 | |
| Merck Sharp & Dohme LLC | $31.78 | 2019-2024 | Keytruda |
| Aveo Pharmaceuticals, INC. | $20.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 2020 | |
| Karyopharm Therapeutics INC. | $12.45 | 2020 | |
| Acrotech Biopharma INC. | $11.97 | 2021 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Clovis Oncology, INC. | $7.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Cherny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.